 | IVF | Name: | N-(iodoacetyl)-L-valyl-L-phenylalaninamide | Formula: | C16 H22 I N3 O3 | SMILES: | ICC(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)C(C)C | InChi: | InChI=1S/C16H22IN3O3/c1-10(2)14(20-13(21)9-17)16(23)19-12(15(18)22)8-11-6-4-3-5-7-11/h3-7,10,12,14H,8-9H2,1-2H3,(H2,18,22)(H,19,23)(H,20,21)/t12-,14-/m0/s1 | Synonyms: | iodoacetyl-valyl-phenylalanyl-amide | Definition date: | 2012-05-07 | Last modified: | 2024-09-27 | Identifier: | N-(iodoacetyl)-L-valyl-L-phenylalaninamide |
|
 | IWW | Name: | [(E)-ethene-1,2-diylbis(3-chloro-4,1-phenylene)]diboronic acid | Formula: | C14 H12 B2 Cl2 O4 | SMILES: | c1(cc(c(cc1)C=Cc2ccc(cc2Cl)B(O)O)Cl)B(O)O | InChi: | InChI=1S/C14H12B2Cl2O4/c17-13-7-11(15(19)20)5-3-9(13)1-2-10-4-6-12(16(21)22)8-14(10)18/h1-8,19-22H/b2-1+ | Definition date: | 2016-12-07 | Last modified: | 2024-09-27 | Release date: | 2017-09-27 | Identifier: | [(E)-ethene-1,2-diylbis(3-chloro-4,1-phenylene)]diboronic acid |
|
 | IY8 | Name: | methoxy-[(~{E},3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]tridec-11-enyl]phosphinous acid | Formula: | C19 H35 O6 P | SMILES: | COC(=O)[CH]([CH](CCCCCCCC=CC)CC[P](O)(=O)OC)C(C)=O | InChi: | InChI=1S/C19H35O6P/c1-5-6-7-8-9-10-11-12-13-17(14-15-26(22,23)25-4)18(16(2)20)19(21)24-3/h5-6,17-18H,7-15H2,1-4H3,(H,22,23)/b6-5+/t17-,18+/m1/s1 | Definition date: | 2022-04-20 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | methoxy-[(~{E},3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]tridec-11-enyl]phosphinic acid |
|
 | IYR | Name: | 3-IODO-TYROSINE | Formula: | C9 H10 I N O3 | SMILES: | Ic1cc(ccc1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-iodo-L-tyrosine |
|
 | IZO | Name: | (2S)-2-AMINOHEX-5-YNOIC ACID | Formula: | C6 H9 N O2 | SMILES: | O=C(O)C(N)CCC#C | InChi: | InChI=1S/C6H9NO2/c1-2-3-4-5(7)6(8)9/h1,5H,3-4,7H2,(H,8,9)/t5-/m0/s1 | Definition date: | 2010-08-09 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-aminohex-5-ynoic acid |
|
 | IZS | Name: | ethyl 2-[(4,6-diethylpyrimidin-2-yl)-methyl-amino]ethanoate | Formula: | C13 H21 N3 O2 | SMILES: | CCOC(=O)CN(C)c1nc(CC)cc(CC)n1 | InChi: | InChI=1S/C13H21N3O2/c1-5-10-8-11(6-2)15-13(14-10)16(4)9-12(17)18-7-3/h8H,5-7,9H2,1-4H3 | Definition date: | 2023-08-04 | Last modified: | 2024-09-27 | Release date: | 2023-10-25 | Identifier: | ethyl 2-[(4,6-diethylpyrimidin-2-yl)-methyl-amino]ethanoate |
|
 | J00 | Name: | 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid | Formula: | C10 H9 B O4 | SMILES: | OB1O[CH](C(=C)C(O)=O)c2ccccc12 | InChi: | InChI=1S/C10H9BO4/c1-6(10(12)13)9-7-4-2-3-5-8(7)11(14)15-9/h2-5,9,14H,1H2,(H,12,13)/t9-/m1/s1 | Synonyms: | (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid | Definition date: | 2021-03-08 | Last modified: | 2024-09-27 | Release date: | 2021-08-04 | Identifier: | 2-[(3~{S})-1-oxidanyl-3~{H}-2,1-benzoxaborol-3-yl]prop-2-enoic acid |
|
 | J02 | Name: | 2-methyl-1-[[1-[(4-nitrophenyl)methyl]-1,2,3-triazol-4-yl]methylamino]-1-oxidanylidene-propane-2-sulfonic acid | Formula: | C14 H17 N5 O6 S | SMILES: | CC(C)(C(=O)NCc1cn(Cc2ccc(cc2)[N+]([O-])=O)nn1)[S](O)(=O)=O | InChi: | InChI=1S/C14H17N5O6S/c1-14(2,26(23,24)25)13(20)15-7-11-9-18(17-16-11)8-10-3-5-12(6-4-10)19(21)22/h3-6,9H,7-8H2,1-2H3,(H,15,20)(H,23,24,25) | Definition date: | 2019-01-08 | Last modified: | 2024-09-27 | Release date: | 2020-04-08 | Identifier: | 2-methyl-1-[[1-[(4-nitrophenyl)methyl]-1,2,3-triazol-4-yl]methylamino]-1-oxidanylidene-propane-2-sulfonic acid |
|
 | J05 | Name: | 1-[[1-[(4-bromophenyl)methyl]-1,2,3-triazol-4-yl]methylamino]-2-methyl-1-oxidanylidene-propane-2-sulfonic acid | Formula: | C14 H17 Br N4 O4 S | SMILES: | CC(C)(C(=O)NCc1cn(Cc2ccc(Br)cc2)nn1)[S](O)(=O)=O | InChi: | InChI=1S/C14H17BrN4O4S/c1-14(2,24(21,22)23)13(20)16-7-12-9-19(18-17-12)8-10-3-5-11(15)6-4-10/h3-6,9H,7-8H2,1-2H3,(H,16,20)(H,21,22,23) | Definition date: | 2019-01-08 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-[[1-[(4-bromophenyl)methyl]-1,2,3-triazol-4-yl]methylamino]-2-methyl-1-oxidanylidene-propane-2-sulfonic acid |
|
 | J0B | Name: | 1-[(3~{R})-3-(4-azanyl-3-iodanyl-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]propan-1-one | Formula: | C13 H17 I N6 O | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(I)c3c(N)ncnc23 | InChi: | InChI=1S/C13H17IN6O/c1-2-9(21)19-5-3-4-8(6-19)20-13-10(11(14)18-20)12(15)16-7-17-13/h7-8H,2-6H2,1H3,(H2,15,16,17)/t8-/m1/s1 | Definition date: | 2019-01-10 | Last modified: | 2024-09-27 | Release date: | 2019-05-22 | Identifier: | 1-[(3~{R})-3-(4-azanyl-3-iodanyl-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]propan-1-one |
|
 | J0E | Name: | 1-[(3~{R})-3-[4-azanyl-3-(4-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | Formula: | C19 H22 N6 O2 | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(c3ccc(O)cc3)c4c(N)ncnc24 | InChi: | InChI=1S/C19H22N6O2/c1-2-15(27)24-9-3-4-13(10-24)25-19-16(18(20)21-11-22-19)17(23-25)12-5-7-14(26)8-6-12/h5-8,11,13,26H,2-4,9-10H2,1H3,(H2,20,21,22)/t13-/m1/s1 | Definition date: | 2019-01-10 | Last modified: | 2024-09-27 | Release date: | 2019-05-22 | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-(4-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one |
|
 | J13 | Name: | (1S,2R,3R,4S,6S)-6-[(8-azidooctanoyl)amino]-2,3,4-trihydroxycyclohexane-1-carboxylate | Formula: | C15 H26 N4 O7 | SMILES: | C1(C(C(C(C(C1)O)O)O)C(=O)[O-])NC(=O)CCCCCCCN=[N+]=[N-] | InChi: | InChI=1S/C15H26N4O7/c16-19-17-7-5-3-1-2-4-6-8(20)18-10-9(15(25)26)11(21)13(23)14(24)12(10)22/h9-14,21-24H,1-7H2,(H,18,20)(H,25,26)/t9-,10+,11+,12-,13-,14-/m0/s1 | Definition date: | 2016-03-22 | Last modified: | 2024-09-27 | Release date: | 2017-04-12 | Identifier: | (1S,2R,3R,4S,6S)-6-[(8-azidooctanoyl)amino]-2,3,4-trihydroxycyclohexane-1-carboxylate |
|
 | J2C | Name: | 8-(2-chloroacetyl)-4-(furan-2-ylmethyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one | Formula: | C14 H17 Cl N2 O3 S | SMILES: | ClCC(=O)N1CCC2(CC1)SCC(=O)N2Cc3occc3 | InChi: | InChI=1S/C14H17ClN2O3S/c15-8-12(18)16-5-3-14(4-6-16)17(13(19)10-21-14)9-11-2-1-7-20-11/h1-2,7H,3-6,8-10H2 | Definition date: | 2021-03-24 | Last modified: | 2024-09-27 | Release date: | 2022-02-16 | Identifier: | 8-(2-chloranylethanoyl)-4-(furan-2-ylmethyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one |
|
 | J2F | Name: | (2~{S})-2-azanyl-3-[4-[(2-nitrophenyl)methoxy]phenyl]propanoic acid | Formula: | C16 H16 N2 O5 | SMILES: | N[CH](Cc1ccc(OCc2ccccc2[N+]([O-])=O)cc1)C(O)=O | InChi: | InChI=1S/C16H16N2O5/c17-14(16(19)20)9-11-5-7-13(8-6-11)23-10-12-3-1-2-4-15(12)18(21)22/h1-8,14H,9-10,17H2,(H,19,20)/t14-/m0/s1 | Definition date: | 2022-08-04 | Last modified: | 2024-09-27 | Release date: | 2022-09-21 | Identifier: | (2~{S})-2-azanyl-3-[4-[(2-nitrophenyl)methoxy]phenyl]propanoic acid |
|
 | J30 | Name: | 4-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-4-oxobutane-1-thiol | Formula: | C19 H24 N2 O S | SMILES: | O=C(N3CCN(Cc1cccc2c1cccc2)CC3)CCCS | InChi: | InChI=1S/C19H24N2OS/c22-19(9-4-14-23)21-12-10-20(11-13-21)15-17-7-3-6-16-5-1-2-8-18(16)17/h1-3,5-8,23H,4,9-15H2 | Definition date: | 2010-09-14 | Last modified: | 2024-09-27 | Identifier: | 1-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-4-sulfanylbutan-1-one |
|
 | J3D | Name: | N-carboxy-L-cysteine | Formula: | C4 H7 N O4 S | SMILES: | C(S)C(C(O)=O)NC(=O)O | InChi: | InChI=1S/C4H7NO4S/c6-3(7)2(1-10)5-4(8)9/h2,5,10H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1 | Definition date: | 2018-08-06 | Last modified: | 2024-09-27 | Release date: | 2019-08-07 | Identifier: | N-carboxy-L-cysteine |
|
 | J3H | Name: | 1-[(3~{R})-3-(4-azanylpyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]propan-1-one | Formula: | C13 H18 N6 O | SMILES: | CCC(=O)N1CCC[CH](C1)n2ncc3c(N)ncnc23 | InChi: | InChI=1S/C13H18N6O/c1-2-11(20)18-5-3-4-9(7-18)19-13-10(6-17-19)12(14)15-8-16-13/h6,8-9H,2-5,7H2,1H3,(H2,14,15,16)/t9-/m1/s1 | Definition date: | 2019-01-17 | Last modified: | 2024-09-27 | Release date: | 2019-05-22 | Identifier: | 1-[(3~{R})-3-(4-azanylpyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]propan-1-one |
|
 | J3K | Name: | (2~{R})-1-azanylpropan-2-ol | Formula: | C3 H9 N O | SMILES: | C[CH](O)CN | InChi: | InChI=1S/C3H9NO/c1-3(5)2-4/h3,5H,2,4H2,1H3/t3-/m1/s1 | Definition date: | 2019-01-17 | Last modified: | 2024-09-27 | Release date: | 2020-04-15 | Identifier: | (2~{R})-1-azanylpropan-2-ol |
|
 | J3N | Name: | 1-[(3~{R})-3-[4-azanyl-3-(1~{H}-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | Formula: | C20 H22 N8 O | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(c3cnc4[nH]ccc4c3)c5c(N)ncnc25 | InChi: | InChI=1S/C20H22N8O/c1-2-15(29)27-7-3-4-14(10-27)28-20-16(18(21)24-11-25-20)17(26-28)13-8-12-5-6-22-19(12)23-9-13/h5-6,8-9,11,14H,2-4,7,10H2,1H3,(H,22,23)(H2,21,24,25)/t14-/m1/s1 | Definition date: | 2019-01-18 | Last modified: | 2024-09-27 | Release date: | 2019-05-22 | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-(1~{H}-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one |
|
 | J3T | Name: | [4-[(4~{S})-4-oxidanyl-5-oxidanylidene-1,3,2-dioxaborolan-2-yl]phenyl]methyl carbamimidothioate | Formula: | C10 H11 B N2 O4 S | SMILES: | NC(=N)SCc1ccc(cc1)B2O[CH](O)C(=O)O2 | InChi: | InChI=1S/C10H11BN2O4S/c12-10(13)18-5-6-1-3-7(4-2-6)11-16-8(14)9(15)17-11/h1-4,8,14H,5H2,(H3,12,13)/t8-/m0/s1 | Definition date: | 2019-01-18 | Last modified: | 2024-09-27 | Release date: | 2020-02-05 | Identifier: | [4-[(4~{S})-4-oxidanyl-5-oxidanylidene-1,3,2-dioxaborolan-2-yl]phenyl]methyl carbamimidothioate |
|
 | J3X | Name: | 4-((5-bromofuran-2-yl)methyl)-8-(2-chloroacetyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one | Formula: | C14 H16 Br Cl N2 O3 S | SMILES: | ClCC(=O)N1CCC2(CC1)SCC(=O)N2Cc3oc(Br)cc3 | InChi: | InChI=1S/C14H16BrClN2O3S/c15-11-2-1-10(21-11)8-18-13(20)9-22-14(18)3-5-17(6-4-14)12(19)7-16/h1-2H,3-9H2 | Definition date: | 2021-04-02 | Last modified: | 2024-09-27 | Release date: | 2022-02-16 | Identifier: | 4-[(5-bromanylfuran-2-yl)methyl]-8-(2-chloranylethanoyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one |
|
 | J4W | Name: | tert-butyl (1-hydroxy-1,3-dihydro-2,1-benzoxaborol-6-yl)carbamate | Formula: | C12 H16 B N O4 | SMILES: | O=C(Nc1cc2c(cc1)COB2O)OC(C)(C)C | InChi: | InChI=1S/C12H16BNO4/c1-12(2,3)18-11(15)14-9-5-4-8-7-17-13(16)10(8)6-9/h4-6,16H,7H2,1-3H3,(H,14,15) | Definition date: | 2016-09-28 | Last modified: | 2024-09-27 | Release date: | 2017-01-11 | Identifier: | tert-butyl (1-hydroxy-1,3-dihydro-2,1-benzoxaborol-6-yl)carbamate |
|
 | J50 | Name: | 8-(2-chloroacetyl)-4-((5-phenylfuran-2-yl)methyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one | Formula: | C20 H21 Cl N2 O3 S | SMILES: | ClCC(=O)N1CCC2(CC1)SCC(=O)N2Cc3oc(cc3)c4ccccc4 | InChi: | InChI=1S/C20H21ClN2O3S/c21-12-18(24)22-10-8-20(9-11-22)23(19(25)14-27-20)13-16-6-7-17(26-16)15-4-2-1-3-5-15/h1-7H,8-14H2 | Definition date: | 2021-04-09 | Last modified: | 2024-09-27 | Release date: | 2022-02-16 | Identifier: | 8-(2-chloranylethanoyl)-4-[(5-phenylfuran-2-yl)methyl]-1-thia-4,8-diazaspiro[4.5]decan-3-one |
|
 | J54 | Name: | (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID | Formula: | C11 H14 N2 O4 | SMILES: | O=C(O)C(O)CNC(=O)NCc1ccccc1 | InChi: | InChI=1S/C11H14N2O4/c14-9(10(15)16)7-13-11(17)12-6-8-4-2-1-3-5-8/h1-5,9,14H,6-7H2,(H,15,16)(H2,12,13,17)/t9-/m1/s1 | Definition date: | 2007-06-13 | Last modified: | 2024-09-27 | Identifier: | (2R)-3-[(benzylcarbamoyl)amino]-2-hydroxypropanoic acid |
|
 | J5B | Name: | (3R)-3-hydroxybutyl alpha-D-glucopyranoside | Formula: | C10 H20 O7 | SMILES: | C[CH](O)CCO[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C10H20O7/c1-5(12)2-3-16-10-9(15)8(14)7(13)6(4-11)17-10/h5-15H,2-4H2,1H3/t5-,6-,7-,8+,9-,10+/m1/s1 | Synonyms: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(3~{R})-3-oxidanylbutoxy]oxane-3,4,5-triol | Definition date: | 2019-01-26 | Last modified: | 2024-09-27 | Release date: | 2019-02-06 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(3~{R})-3-oxidanylbutoxy]oxane-3,4,5-triol |
|